Sinopharm: Discovers antibody agst Delta variant, early treatment of COVID-19
#1

The team, led by Yang Xiaoming, Chairman of Sinopharm China National Biotec Group, a Sinopharm subsidiary, found a monoclonal antibody which can effectively block the binding of novel coronavirus to the Angiotensin-converting enzyme 2. 

This enzyme is attached to the membrane of cells located in the intestines, kidney, testis, gallbladder, and heart and the antibody can prevent the virus from infecting cells, the company announced on its official WeChat account.

The research is expected to be a useful weapon against virus mutation.

https://www.globaltimes.cn/page/202108/1230617.shtml
[+] 2 users Like theold's post
Reply
#2

Clapping
[+] 1 user Likes babygirl's post
Reply
#3

Sinopharm huat ah

8Umbrella Umbrella
Reply
#4

(05-08-2021, 05:47 PM)theold Wrote:  The team, led by Yang Xiaoming, Chairman of Sinopharm China National Biotec Group, a Sinopharm subsidiary, found a monoclonal antibody which can effectively block the binding of novel coronavirus to the Angiotensin-converting enzyme 2. 

This enzyme is attached to the membrane of cells located in the intestines, kidney, testis, gallbladder, and heart and the antibody can prevent the virus from infecting cells, the company announced on its official WeChat account.

The research is expected to be a useful weapon against virus mutation.

https://www.globaltimes.cn/page/202108/1230617.shtml

Is this vaccine available in private clinics..? Huh
Reply
#5

(05-08-2021, 08:48 PM)debono Wrote:  Is this vaccine available in private clinics..? Huh

I registered my interest for it.
Reply


Forum Jump:


Users browsing this thread: 2 Guest(s)